Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Adherence" wg kryterium: Temat


Wyświetlanie 1-3 z 3
Tytuł:
ACNE IN BULGARIA AND GREECE: COMPARISON STUDY OF PATIENT ADHERENCE
Autorzy:
Petkova, Valentina
Hussain, Shahnaz
Filinada, Dimitra
Karamisheva, Vesela
Powiązania:
https://bibliotekanauki.pl/articles/895474.pdf
Data publikacji:
2019-10-30
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
Greece
adherence
acne
Bulgaria
ECOB scale
Opis:
Background: Acne vulgaris is a chronic inflammatory disorder of the skin. Low level of adherence of acne patients to treatment can lead to poor clinical efficacy, increased healthcare costs, and unnecessary treatments that can lead to adverse drug reactions. Objective: The aim of this study is to compare the level of adherence of acne patients between Greece and Bulgaria. Methods: A multicenter observational study utilized self-completed questionnaires to assess medication adherence among patients visiting 45 pharmacies throughout Bulgaria and Greece between May and December 2018. A total of 225 patients were included in the study. Subjects included acne patients undergoing treatment who had a medical consultation prior to the study. All patients had acne therapy prescriptions. The likelihood of adherence was assessed using the Elaboration d'un outil d'evaluation de l'observance (ECOB) Adherence Questionnaire. Adherence Questionnaire. The ECOB scale was translated into Bulgarian and standardized by forward translation, backward translation, and a pretest. The data collected were proceeded through SPSS ver. 22.0. Results: According to the ECOB scores, good adherence to treatment was documented in 42.0 % of the Bulgarian patients on topical treatment and 39 on oral medication. For the Greek patients good adherence to topical medication was judged to be good for 53% and for 40% on oral treatment. Conclusion. Greek and Bulgarian patients show similar level - of high rate of non-adherence to acne treatment. Perhaps patients could be monitored about their adherence and this can be performed in the dermatology clinic or in the pharmacy.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2019, 76, 5; 913-916
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Health behaviour of elderly patients with heart failure in Poland associated with pharmacotherapy and non-pharmacological treatment
Autorzy:
Makarewicz-Wujec, Magdalena
Janas, Ewelina
Kozłowska-Wojciechowska, Małgorzata
Powiązania:
https://bibliotekanauki.pl/articles/895264.pdf
Data publikacji:
2019-04-30
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
heart failure
health behaviour
adherence
elderly patients
Opis:
Introduction. In Poland, it is estimated that HF is observed in approximately 0,7 million of patients. The aim of the study was to assess health behaviour in geriatric patients diagnosed with HF regarding pharmacotherapy and non-pharmacological treatment. Material and methods. The study group comprised 72 patients with diagnosed HF, over 65y. The study was performed using a questionnaire survey including 20 closed-ended questions. Results. The mean number of medicinal products prescribed by physicians for the treatment of HF and other diseases was 6.59±1.8. 50% of subjects were additionally taking medications and supplements for self-treatment, 63% declared they managed to take medications prescribed on their own. A diet is followed only by 50%, but only 18% limit their sodium intake. 46% still consume alcohol, and 10% of still smoke cigarettes. 46% declared the use of body weight monitoring, but none of them measured their body weight every day. Conclusion. Health behaviour of geriatric patients with HF in Poland indicates their low compliance with medical guidelines and it may explain a high hospitalisation rate and increasing costs of treatment.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2019, 76, 2; 367-374
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Impact of education on dimensions of adherence in patients with chronic obstructive pulmonary disease
Autorzy:
Olah, Mate
Kresznerits, Szilvia
Gonda, Xenia
Perczel-Forintos, Dora
Szabo, Miklos
Csanky, Eszter
Meszaros, Agnes
Powiązania:
https://bibliotekanauki.pl/articles/895711.pdf
Data publikacji:
2020-02-29
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
quality of life
COPD
adherence
patient education
Opis:
Objectives To assess the impact of patient education on medication adherence and quality-of-life (QoL) in Hungarian subjects with chronic obstructive pulmonary disease (COPD). Study Design Longitudinal, non-interventional study conducted at three pulmonology outpatient centers in and around Budapest, Hungary. Experimental Subjects visiting the center with COPD were invited to participate in the study. Data collected at baseline included subject demographics, medical history, and responses to the adherence (Morisky Medication Adherence Scale-8 (MMAS-8)) and QoL (EuroQoL-5D-5L (EQ5D), St. George’s Respiratory Questionnaire (SGRQ), and COPD Assessment Tool (CAT)) scales. Subjects were also provided with patient education designed with standardized content. Subjects were asked to provide responses to adherence and QoL scales again at the 3-month follow-up visit. Medication was left unchanged during the course of study. Statistical analysis included independent and paired-samples t-tests, one-way ANOVA, mixed-measures ANOVA and ANCOVA. Results Mean (± standard deviation (SD)) overall adherence score on MMAS-8 scale increased from 6.72 (± 1.46) at baseline to 7.01 (± 1.15) at follow-up (P = .040). A similar increase in mean (± SD) score was observed for question 4 on the MMAS-8 which deals with remembering to carry COPD medication when leaving house (baseline = 0.81 (± 0.40) versus follow-up = 0.89 (± 0.31); P = 0.018). Conclusions Patient education has a positive outcome on medication adherence in subjects with COPD. Further studies will be required to assess if these benefits are translated to patients’ QoL.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2020, 77, 1; 195-204
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
  • odwiedzone
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies